News

NIH expands cancer research program to include breast density


 

References

Officials at the National Institutes of Health are taking a closer look at the role that breast density plays in the development of breast cancer.

As part of the agency’s Breast Cancer and the Environment Research Program (BCERP), grant-funded researchers are being tasked with expanding the study of risk factors that precede breast cancer such as breast density. They will also include more racially and ethnically diverse populations in their studies.

Dr. Cecil Fox/National Cancer Institute

The research will be conducted at six centers: Brigham and Women’s Hospital, Boston; City of Hope/Beckman Research Institute, Duarte, Calif.; Columbia University, New York; Georgetown Lombardi Comprehensive Cancer Center, Washington; Michigan State University, Lansing; University of Massachusetts, Amherst. The research will be coordinated by another center at the University of Wisconsin, Madison.

Breast density is a new area of focus for the NIH. The researchers will consider dense breast tissue as a possible intermediate risk factor for breast cancer with the goal of identifying links between environmental exposures and high breast density, which could provide future prevention strategies.

“These priorities reflect our continued commitment to breast cancer prevention,” Caroline H. Dilworth, Ph.D., BCERP program lead at the National Institute of Environmental Health Sciences, said in a statement. “Our goal is to build on the high-quality science we’ve been funding for more than a decade, while also being responsive to the expert recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee] report.”

mschneider@frontlinemedcom.com

On Twitter @maryellenny

Recommended Reading

Weight program effective for breast cancer survivors
MDedge Family Medicine
Genetic biomarkers may be best bet for augmenting mammography screening
MDedge Family Medicine
DCIS: Recurrence risk rises after forgoing radiotherapy
MDedge Family Medicine
More genomic instability found in breast tumors of black women
MDedge Family Medicine
LCIS: 2% annual cancer risk, less than 1% with chemoprevention
MDedge Family Medicine
DCIS recurrences have declined significantly
MDedge Family Medicine
ASCO: MRI improved breast cancer detection in average risk women
MDedge Family Medicine
ASCO: Many women with triple-negative breast cancer aren’t screened for BRCA
MDedge Family Medicine
Computer-aided detection fails to improve mammographic accuracy
MDedge Family Medicine
VIDEO: When to use MRI in breast cancer
MDedge Family Medicine